男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

China still to fully reimburse cost for COVID treatment

By Li Lei | chinadaily.com.cn | Updated: 2023-01-07 16:08
Share
Share - WeChat
A medical worker in a protective suit adjusts a monitoring device for a patient at the fever clinics of the Third Hospital of Hebei Medical University. [Photo by Wang Zhuangfei/China Daily]

Hospitalization cost for COVID-19 patients will continue to be fully reimbursed until the end of March, a circular said on Saturday, despite China's decision to downgrade the disease' management from Class A to Class B on Sunday.

Released by four departments including the National Healthcare Security Administration and the Ministry of Finance, the circular said hospitalization costs that confirm to the diagnosis and treatment plan for novel coronavirus infections -- as COVID-19 is officially known -- will still be reimbursed as before.

The costs will be shared between several State-run healthcare plans -- such as the country's basic medical insurance and the issuance for severe illnesses -- and local finance authorities, the circular said.

It added that 60 percent of the spending by local government will be later paid by the central finance authorities.

To ease pressure for top hospitals, the circular said patients seeking medical advice at Grade 1 hospitals, or the grassroots medical institutions such as township hospitals, will have at least 70 percent of their spending covered by the State. The exact ratio will be decided by local medical insurance and finance departments in light of local balancing situations.

The medical fees incurred by COVID-19 patients at other higher level hospitals will be the same with other Class B infectious diseases, which has a threshold and a cap for reimbursement, it said.

Places facing a shortage of medications are allowed to add more drugs to the catalog of reimbursable medicines.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 冷水江市| 大安市| 皮山县| 曲阳县| 高要市| 奇台县| 双鸭山市| 米林县| 岳池县| 昌平区| 垣曲县| 蛟河市| 双鸭山市| 藁城市| 江城| 长武县| 安康市| 湟中县| 绥阳县| 红河县| 城口县| 盐源县| 隆昌县| 长治县| 彭阳县| 丰顺县| 宁远县| 樟树市| 交城县| 金堂县| 偏关县| 浪卡子县| 东丰县| 罗平县| 项城市| 沈丘县| 青田县| 阿瓦提县| 广元市| 新乐市| 南昌县|